Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
The Auto-disable Syringes Market size was estimated at USD 23.28 billion in 2023 and expected to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Auto-disable Syringes Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Auto-disable Syringes Market, highlighting leading vendors and their innovative profiles. These include AccuPoint by AdvaCare Pharma, Al Shifa Medical Products Co., Apple Syringe, Becton Dickinson & Company, Duopross Meditech Corp., Hindustan Syringes & Medical Devices Ltd, Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co., Injecto A/S, Iscon Surgicals Ltd., JMI SYRINGES & MEDICAL DEVICES LTD., Merck KGaA, PT Oneject Indonesia, Retractable Technologies, Inc., Sanavita Pharmaceuticals GmbH, Shandong Zhushi Pharmaceutical Group Co.,Ltd., Shanghai Kohope Medical Devices Co., Ltd., Shenzhen Medis Medical, and Terumo Corporation.
Market Segmentation & Coverage
This research report categorizes the Auto-disable Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:
Indication
Infectious Diseases
Inflammatory/Auto-Immune Diseases
Application
Blood Collection
Drug Delivery
Vaccination
End-User
Ambulatory Surgical Centers
Diagnostic Laboratories
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom The report offers valuable insights on the following aspects:
Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
What is the market size and forecast of the Auto-disable Syringes Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Auto-disable Syringes Market?
What are the technology trends and regulatory frameworks in the Auto-disable Syringes Market?
What is the market share of the leading vendors in the Auto-disable Syringes Market?
Which modes and strategic moves are suitable for entering the Auto-disable Syringes Market?
Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Auto-disable Syringes Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of needle stick injuries and cross infection
5.1.1.2. Significant preference of healthcare organizations towards the use of auto-disable syringes
5.1.1.3. Increasing demand for immunization coverage
5.1.2. Restraints
5.1.2.1. High cost of procurement and raw material
5.1.3. Opportunities
5.1.3.1. Increasing scope in mass application campaign
5.1.3.2. Ongoing advancements in auto-disable syringes
5.1.4. Challenges
5.1.4.1. Concern regarding unsafe injection practices and logistic challenges
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Auto-disable Syringes Market, by Indication
6.1. Introduction
6.2. Infectious Diseases
6.3. Inflammatory/Auto-Immune Diseases
7. Auto-disable Syringes Market, by Application
7.1. Introduction
7.2. Blood Collection
7.3. Drug Delivery
7.4. Vaccination
8. Auto-disable Syringes Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Laboratories
8.4. Hospitals
9. Americas Auto-disable Syringes Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Auto-disable Syringes Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Auto-disable Syringes Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AccuPoint by AdvaCare Pharma
13.1.2. Al Shifa Medical Products Co.
13.1.3. Apple Syringe
13.1.4. Becton Dickinson & Company
13.1.5. Duopross Meditech Corp.
13.1.6. Hindustan Syringes & Medical Devices Ltd
13.1.7. Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
13.1.8. Injecto A/S
13.1.9. Iscon Surgicals Ltd.
13.1.10. JMI SYRINGES & MEDICAL DEVICES LTD.
13.1.11. Merck KGaA
13.1.12. PT Oneject Indonesia
13.1.13. Retractable Technologies, Inc.
13.1.14. Sanavita Pharmaceuticals GmbH
13.1.15. Shandong Zhushi Pharmaceutical Group Co.,Ltd.
13.1.16. Shanghai Kohope Medical Devices Co., Ltd.
13.1.17. Shenzhen Medis Medical
13.1.18. Terumo Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. AUTO-DISABLE SYRINGES MARKET RESEARCH PROCESS
FIGURE 2. AUTO-DISABLE SYRINGES MARKET SIZE, 2023 VS 2030